The GLP-1 semaglutide is the active ingredient in Ozempic and Wegovy, both sold by the company Novo NordiskPhoto: Ricardo Rubio (AP)
New research this month is the latest to link the use of Ozempic, Wegovy, and other GLP-1 drugs to a greater risk of …